Germany-based Ovom Care has raised €4.8 million in seed funding led by Alpha Intelligence Capital and supported by Ananda Impact Ventures and Merantix. The company combines hybrid reproductive care with advanced AI solutions, aiming to improve patient outcomes and expand fertility access to women at more affordable rates. To date Ovom Care has treated over 100 patients in its London clinic and…
Maven Clinic has unveiled significant expansions to its Fertility and Family Building program, aiming to address critical gaps in preconception care and support for couples trying to conceive. The latest updates include the launch of Maven’s Trying-To-Conceive (TTC) health coaching program, designed to provide personalized guidance and support for individuals navigating the challenges of conception without resorting to costly IVF treatments. With…
Stork Club Reproductive Care has achieved a significant milestone, extending its reach to 100 countries globally and providing access to over 8,000 in-network providers. The company has also introduced an innovative Direct Pay system, simplifying the member experience by eliminating the need for virtual benefits cards. This expansion of Stork Club, an enterprise reproductive care benefits solution, ensures that critical reproductive and…
Fertility tech company TMRW Life Sciences has introduced CryoLink, a workstation designed to facilitate the digital management of frozen specimen inventories in fertility clinics. This solution allows clinics to integrate TMRW’s Digital Specimen Management system into their existing storage infrastructure, offering a safe and efficient upgrade to their current processes. Previously, access to TMRW’s Digital Specimen Management system was limited to clinics…
Alife Health, a leading fertility technology company specializing in AI tools for in vitro fertilization (IVF), has announced a strategic partnership with Boston IVF, a prominent fertility clinic with over 25 locations across the U.S. The collaboration aims to implement the country’s first AI tool for IVF medication optimization, with the objective of enhancing patient outcomes through data-driven decisions. The collaboration between…
French women’s health company Womed recently announced significant advancements in the treatment of intrauterine adhesions (IUAs), a major cause of female infertility, with its product, Womed Leaf. The announcement came following the successful results of the PREG2 clinical trial, which were shared by Prof. Jean-Louis Benifla during the Choix des Armes conference in Marseille, France and suggest that Womed’s technology can help…
Biomedical company Femasys has successfully completed the first commercial procedure using its innovative FemaSeed intratubal insemination product. FemaSeed, which has received clearance from the U.S. FDA, employs a novel approach to enhance fertilization by precisely delivering sperm directly to the fallopian tube—the natural site of conception. This method is designed to be a primary therapeutic choice for those seeking pregnancy, offering reduced…
Two years have passed since Oya Care announced its $3 million seed funding round, secured from Susa Ventures, with additional investment from Brazilian entities Canary, Positive, and IKJ. In that time, the company has made significant progress, prompting us to sit down with Stephanie von Staa Toledo, Oya’s Founder & CEO, to discuss her journey as she works to position Oya as…
